Literature DB >> 12400736

Surgical resection of lung cancer in patients with underlying interstitial lung disease.

Emmanuel Martinod1, Jacques F Azorin, Danielle Sadoun, Marie-Dominique Destable, Philippe Le Toumelin, Elisabeth Longchampt, Marianne Kambouchner, Loïc Guillevin, Dominique Valeyre.   

Abstract

BACKGROUND: The association between interstitial lung disease (ILD) and an increased risk of developing lung cancer has been reported. The goal of this retrospective study was to determine the outcome of lung cancer resection among patients with ILD.
METHODS: Between January 1979 and March 1999, 27 patients with both lung cancer and ILD were identified. Seven patients with poor pulmonary function tests or distant metastases underwent medical treatment and were excluded from this study. Twenty patients treated by surgical resection were analyzed.
RESULTS: Various types of ILD such as sarcoidosis (n = 7), idiopathic interstitial pneumonia (n = 4), histiocytosis X (n = 4), pneumoconiosis (n = 4), and amiodarone-induced ILD (n = 1) were observed. Tumors were located in the peripheral part of the lung in 16 cases. The most frequent tumor cell types were squamous and adenocarcinoma. The resections consisted of lobectomy (n = 16), bilobectomy (n = 1), and pneumonectomy (n = 3). Most cancers were stage I (n = 10) or II (n = 6). There was no postoperative death. The postoperative course was uneventful in 16 cases. The majority of patients (70%) did not experience respiratory insufficiency during the follow-up period. The actuarial 2-year and 5-year survival rates were, respectively, 83.5% and 66.4%.
CONCLUSIONS: In this series, the long-term survival of patients who had lung cancer resection appeared to be not affected by the association with ILD. This could be explained by an adequate preoperative selection based on pulmonary function tests and a preferential choice for lobectomies. Thus, surgical resection should be offered to properly selected patients with lung cancer and underlying ILD.

Entities:  

Mesh:

Year:  2002        PMID: 12400736     DOI: 10.1016/s0003-4975(02)03848-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease.

Authors:  Evans R Fernández-Pérez; Murat Yilmaz; Hussam Jenad; Craig E Daniels; Jay H Ryu; Rolf D Hubmayr; Ognjen Gajic
Journal:  Chest       Date:  2007-11-07       Impact factor: 9.410

2.  What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?

Authors:  Masahiro Miyajima; Atsushi Watanabe; Toshihiko Sato; Satoshi Teramukai; Masahito Ebina; Kazuma Kishi; Yukihiko Sugiyama; Haruhiko Kondo; Satoru Kobayashi; Yutaka Takahashi; Hiroyuki Ito; Ryoji Yamamoto; Shigeki Sawada; Hideki Fujimori; Kazunori Okabe; Jun Arikura; Yasushi Shintani; Hiroshige Nakamura; Shinichi Toyooka; Tohru Hasumi; Takehiro Watanabe; Yoshinobu Hata; Hisashi Iwata; Minoru Aoki; Kazuhito Funai; Shuhei Inoue; Osamu Kawashima; Tomohiko Iida; Hiroshi Date
Journal:  Surg Today       Date:  2017-11-09       Impact factor: 2.549

3.  Outcomes of Older Patients with Pulmonary Fibrosis and Non-Small Cell Lung Cancer.

Authors:  Stacey-Ann Whittaker Brown; Maria Padilla; Grace Mhango; Emanuela Taioli; Charles Powell; Juan Wisnivesky
Journal:  Ann Am Thorac Soc       Date:  2019-08

4.  Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cancer.

Authors:  Taichiro Goto; Arafumi Maeshima; Yoshitaka Oyamada; Ryoichi Kato
Journal:  Int J Clin Oncol       Date:  2013-05-10       Impact factor: 3.402

Review 5.  Pre-operative pulmonary assessment for patients with hip fracture.

Authors:  I-L Lo; C-W Siu; H-F Tse; T-W Lau; F Leung; M Wong
Journal:  Osteoporos Int       Date:  2010-11-06       Impact factor: 4.507

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.